β-Blockers or Clonidine in Antihypertensive Therapy?

  • Hermann A. Trauth
Conference paper


β-receptor blockers are often considered as agents of first choice in antihypertensive therapy (Kewitz 1978). Side-effects are seldom, contraindications must be noted; in bronchial asthma, β-blockers are contraindicated (Burley 1975; Frishman 1979). We carried out a retrospective investigation of 100 randomly sampled hypertensive patients (bronchial asthma had not been noted in the history) treated with β-blockers and with clonidine. Airway resistance, chest complaints and history of respiratory diseases were compared and the incidence of bronchial side-effects by high-dose (e.g. antihypertensive) β-blocker therapy measured.


Allergic Rhinitis Antihypertensive Therapy Airway Resistance Blocker Therapy Cardiac Origin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Burley DM (1975) Therapiewoche 25: 4342–346Google Scholar
  2. 2.
    Frishman Wet al (1979) Am Heart J 98: 256–262Google Scholar
  3. 3.
    Kewitz H (1978) Medizinische und wirtschaftliche rationale Arzneimitteltherapie. Springer, BerlinCrossRefGoogle Scholar
  4. 4.
    Waal-Manning HJ (1976) Drugs 12: 412–441PubMedCrossRefGoogle Scholar
  5. 5.
    Williams JP, Millard FJC (1980) Thorax 35: 160PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • Hermann A. Trauth
    • 1
  1. 1.Medizinische PoliklinikPhilipps-Universität MarburgMarburgGermany

Personalised recommendations